Hi OvF
Yes, TOS was on both healthy and AD.
And there was no significant difference in uptake between them.
That's clear.
But TOS isn't a "current trial".
It finished several years ago.
The unreleased detailed results have been interpreted differently by different CEOs with no explanation from ACW.
The entity which should be educating shareholders on brain physiology is ACW.
The 2019 study sponsored by Astellas mentions the Merck tracer near the start, and it also has a diagram of the Merck tracer molecule. Please ask if you can't find it and I'll post a screenshot.
- Forums
- ASX - By Stock
- ACW
- Target Occupancy Study (TOS)
Target Occupancy Study (TOS), page-36
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.001(3.85%) |
Mkt cap ! $76.57M |
Open | High | Low | Value | Volume |
2.6¢ | 2.7¢ | 2.6¢ | $24.74K | 917.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2443261 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 993192 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 2422646 | 0.026 |
37 | 9640140 | 0.025 |
18 | 4173642 | 0.024 |
21 | 5026667 | 0.023 |
14 | 4776717 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 1462582 | 12 |
0.028 | 2999432 | 9 |
0.029 | 1283218 | 9 |
0.030 | 2366500 | 8 |
0.031 | 1060379 | 5 |
Last trade - 15.00pm 16/10/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |